We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Venus Concept Inc (VERO) USD0.0001

Sell:$0.52 Buy:$0.55 Change: $0.0099 (1.86%)
Market closed |  Prices as at close on 28 May 2024 | Switch to live prices |
Sell:$0.52
Buy:$0.55
Change: $0.0099 (1.86%)
Market closed |  Prices as at close on 28 May 2024 | Switch to live prices |
Sell:$0.52
Buy:$0.55
Change: $0.0099 (1.86%)
Market closed |  Prices as at close on 28 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Venus Concept Inc. is a global medical aesthetic technology company. The Company has a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches in over 60 countries and 14 direct markets. The Company's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. The Company's systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry's traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company's hair loss treatment solutions include the ARTAS Solution and the NeoGraft Solution.

Contact details

Address:
235 Yorkland Blvd Suite 900
TORONTO
M2J 4Y8
Canada
Telephone:
+1 (408) 8836888
Website:
https://www.venusconcept.com/en-uk/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
VERO
ISIN:
US92332W2044
Market cap:
$3.37 million
Shares in issue:
6.36 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Hemanth Varghese
    President, Chief Operating Officer
  • Rajiv De Silva
    Chief Executive Officer, Director
  • Domenic Della Penna
    Chief Financial Officer, Executive Vice President
  • Anna Georgiadis
    Chief Human Resource Officer
  • Ross Portaro
    Executive Vice President and General Manager - Global Sales & Marketing
  • William Mcgrail
    Senior Vice President - Technical Operations and Compliance
  • Michael Mandarello
    General Counsel, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.